Distributed Control System Facilitates Expansion for New Drugs Produced by Contract Manufacturing Organization
Pharma Mirror
DECEMBER 9, 2021
Combatting the pandemic has highlighted the importance of the partnership between biopharma organizations and the contract manufacturing organizations (CMOs) that must flexibly handle outsourced production, which can come suddenly and often must quickly be ramped up.
Let's personalize your content